Full Year Trading Update

Summary by AI BETAClose X

Optima Health plc anticipates its full-year adjusted EBITDA to be approximately 10% ahead of market expectations, with market consensus for FY26 adjusted EBITDA at £18.1 million. The company has made strong progress towards its medium-term targets of £200 million revenue and £40 million adjusted EBITDA, further bolstered by the recent acquisition of PAM, which is expected to yield significant operational and cost synergies. Additionally, the previously disclosed procurement matter has been settled, with £2.3 million recognised in H1 FY26 and a further £2.4 million in H2 FY26 as other operating income.

Disclaimer*

UK 100

Latest directors dealings